5/8/2013

Patients who take drugs that block tumor necrosis factor alpha have a slightly higher risk of complications following surgery to treat inflammatory bowel disease, Canadian researchers reported. Dr. John Marshall of McMaster University said the study should not change physician practice, but should serve as a caution to doctors and patients that they must weigh all the risks and benefits of surgery for IBD.

Related Summaries